Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.
An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.
An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.
Live: Monday 10 June 2024, from 16:30 – 18:00 (CEST)
In this live interactive webinar, a multidisciplinary team of speakers will provide practical guidance on managing patients with cutaneous T-cell lymphoma. Learn about the key aspects of diagnosis and treatment via a series of patient cases.
Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.
Urologist James Catto asks oncologist Thomas Powles key questions on the role of ctDNA in the understanding of urothelial cancer and its potential to improve treatment decision-making in the future.
Next-generation sequencing is a powerful tool that can identify mutations or fusions in a wide range of cancers, enabling physicians to provide targeted therapy to patients and improve outcomes. In this vodcast, Professor Andrew Beggs discusses practical aspects of this technique from the clinical viewpoint.
Severe pain is the most common symptom of chronic pancreatitis. In this live webinar, experts shared the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discussed pertinent cases and provided practical suggestions for use within clinical practice.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.
Dr. Luis Paz-Ares, Prof. Solange Peters and Dr. Marina Garassino provide their insights on the latest findings from the following pivotal phase III trials: ALINA, CheckMate-77T, LIBRETTO-431, and MARIPOSA-1 and -2.
Dr. Laura Locati comments on the LIBRETTO-531 study of selpercatinib in previously untreated RET-mutant medullary thyroid carcinoma, which has provided a new treatment option for this patient population.
Dr. Enrique Grande discusses the findings of the EV-302 trial of enfortumab vedotin plus pembrolizumab and the CheckMate 901 trial of nivolumab plus chemotherapy, both conducted in the advanced urothelial cancer setting.
Dr. Domenica Lorusso takes us through the key gynecologic cancer studies presented at the conference, including the KEYNOTE-A18 and innovaTV 301 trials in cervical cancer and DUO-E in endometrial cancer.
Professor Johann Bauersachs discusses the new ESC guidelines on cardiomyopathy, which for the first time cover the broad range of cardiomyopathies. He highlights some red flags for diagnosis, and the importance of patient involvement in disease management.
Professor Michael Böhm explains the importance of treating iron deficiency in heart failure patients, considering the results of the HEART-FID trial and pooled individual patient data from three RCTs.
Professor Nikolaus Marx discusses the new ESC guidelines on screening and stratification of patients with diabetes, and the importance of person-centred therapeutic strategies to reduce patients' cardiovascular risk.
Watch the official ESC video recording of the presentation of the international guideline for prevention and management of CVD in patients with diabetes.
Watch the official ESC video recording of the presentation of updated international guidelines for the diagnosis and management of patients with infective endocarditis.
